Results

Total Results: 937 records

Showing results for "question".

381. Final Research Plan: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan4/autism-spectrum-disorder-in-young-children-screening
     June 20, 2013 - socioeconomic status) can be important modifiers of screening test performance; the USPSTF added a key question

382. Behavioral Interventions and Counseling to Prevent Child Abuse and Neglect: A Systematic Review to Update the USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SUHq3jffCaucDobFXKewQ_
     February 01, 2013 - Data Synthesis We assessed the aggregate quality of the body of evi- dence for each key question as … RESULTS Key Question 1 For children without obvious signs and symptoms of abuse or neglect but potentially … Key Question 2 What are the adverse effects of behavioral interventions and counseling to reduce harm … Summary of Evidence Key Question Studies Design Limitation Consistency Applicability Overall Quality … 1: 11 trials Key question 2: None Abstracts of potentially relevant articles identified through MEDLINE

383. Archived: Final Research Plan: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan102/chronic-obstructive-pulmonary-disease-screening-2016
     May 15, 2014 - In response, a contextual question on the rescreening interval was added; the rescreening interval is

384. Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k-btyK4W2-v9KnemTK8WDx
     September 14, 2021 - For additional information see the USPSTF Procedure Manual.16 Screening Effectiveness Key Question … country 4 Non–English-language 1866 Citations excluded at title and abstract stage KQ indicates key question … of PID for screening vs home sampling (RR, 0.50 [95% CI, 0.23-1.08]).33 Risk Stratification Key Question … , after adjust- ing for age, sex, and number of sex partners.26 Diagnostic Accuracy of Tests Key Question … Screening Harms Key Question 4.

385. Archived: Final Evidence Summary: Vitamin D and Calcium to Prevent Fractures: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
     December 10, 2011 - outcomes, instead referring to the Ottawa evidence report (which is current up to 2005) 8 for this question … KQ = key question. * Go to “Study Selection” section for detailed population of interest. … KQ = key question; RCT = randomized, controlled trial. … (overarching question) Vitamin D supplementation vs. placebo* Total cancer 2 RCTs ( n = 3577 … stones: HR, 1.17 (CI, 1.02–1.34)   25-(OH)D = 25-hydroxyvitamin D; HR = hazard ratio; KQ = key question

386. From Topic Nomination to Clinical Practice: Making a Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/from-topic-nomination-to-clinical-practice-resources-overview.pdf
     June 01, 2021 - Draft Research Plan includes criteria for the types of evidence that will be reviewed for each key question … Task Force Process Notes Inclusion and exclusion criteria are determined on a topic and key question

387. Archived: Evidence Summary: Screening for Breast Cancer: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-breast-cancer/breast-cancer-screening-january-2016
     January 11, 2016 - We assessed the aggregate internal validity (quality) of the body of evidence for each key question as … KQ = key question. … Of these 10,036 were excluded at the abstract level because they did not address a key question or only … Some studies may have addressed more than one key question, and the trials may have reported data in … † Generally effective randomization and comparable groups are assembled initially, but some question

388. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
     February 13, 2018 - lists, peer reviewers) 1307 Excluded based on review of title, abstract, or both KQ indicates key question … Benefits of Screening Key Question 1. … Screening Protocols for Trials Addressing Ovarian Cancer Mortality (Key Question 1)a Source Screening … with ovarian can- cer did not differ significantly between study groups.21 Harms of Screening Key Question … Effects of Ovarian Cancer Screening on Ovarian Cancer Mortality (Key Question 1)a,b Source Screening

389. Screening for Visual Impairment in Children Younger than Age 5 Years: An Update of the Evidence from Randomized Controlled Trials, 1999–2003 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkowkNFvCYh9hMnEBcCkGh
     May 01, 2004 - This update of the evidence, written in 2003, focuses on the question of whether screening for amblyopia … This question has been added to the analytic framework from the original Systematic Evidence Review ( … flaws noted in the “poor” category below: generally comparable groups are assembled initially but some question

390. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - Key Question 1: Does PSA-Based Screening Decrease Prostate Cancer–Specific or All-Cause Mortality? … Key Question 2: What Are the Harms of PSA-Based Screening for Prostate Cancer? … Key Question 3: What Are the Benefits of Treatment of Early-Stage or Screening-Detected Prostate Cancer … Key Question 4: What Are the Harms of Treatment of Early-Stage or Screening-Detected Prostate Cancer? … Of those, 11 studies were included for key question 1 and 27 studies were included for key question 2

391. Archived: Final Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary39/obesity-in-children-and-adolescents-screening-2010
     January 15, 2010 - Key Question 1 is: "Do weight management programs (behavioral, pharmacological) lead to body mass index … Arrow 2, which proceeds up and to the right, represents Key Question 2, which is: "Do weight management … Arrow 3 represents Key Question 3, which is "What are the adverse effects of weight management programs … From there, an arrow representing Key Question 2 proceeds to the right and forks in two directions. … One arrow, representing Key Question 3, curves down and ends at the oval reading "Adverse effects."

392. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mk-eb9VtB_jx885wnjuzk3
     January 01, 2024 - Benefits of Statin Treatment Key Question 1a. … coronary heart disease; CVA, cerebrovascular accident (stroke); CVD, cardiovascular disease; KQ, key question … Key Question 1b. … e For example, nonsystematic reviews; letters. f Studies may be included for more than 1 key question … Key Question 1c.

393. Archived: Final Evidence Review: Syphilis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review93/syphilis-infection-screening-2004
     July 15, 2004 - Not an RCT 9 Exclude No health outcomes described 10 Exclude Not relevant to key question … New Evidence Key Question … No studies evaluated this question directly.

394. Screening for Syphilis: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8L5g-QzXLDnUofBUE457DN
     July 01, 2004 - Summary of New Evidence Key Question 1. … No studies evaluated this question directly. … care 8 Exclude Not an RCT 9 Exclude No health outcomes described 10 Exclude Not relevant to key question

395. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/boPWHmzrtxnkkPQAoCNENS
     September 18, 2018 - Benefits for Health Outcomes Key Question 1. … Benefits for Weight Control Key Question 2. … Harms of Interventions Key Question 3. … Summary of Evidence, by Key Question and Intervention Type (continued) Inter- vention No. of Studies … Summary of Evidence, by Key Question and Intervention Type (continued) Inter- vention No. of Studies

396. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
     December 21, 2023 - Abbreviations: KQ=key question; MRI=magnetic resonance imaging; PSA=prostate specific antigen.

397. Archived: Evidence Summary: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/depression-in-children-and-adolescents-screening
     February 08, 2016 - Appendix Table 1 and the full evidence report include all of the search strategies used for each key question … studies that at least 1 reviewer indicated as potentially meeting our prespecified criteria for each key question … We rated the overall body of evidence for each key question using the system developed by the USPSTF. … found no trials meeting the inclusion and quality criteria for this review that examined the overall question … Intervention, by Key Question

398. Primary Care Screening for Abdominal Aortic Aneurysm: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XAaYbGVD_xRoMfQ-huJkJq
     December 10, 2019 - Benefits of Screening Key Question 1. … Benefits of Rescreening Key Question 2. … Harms of Screening Key Question 3. … Harms of Early Treatment for Small AAAs Key Question 5. … A summary of the evidence by key question is provided in Table 5.

399. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
     May 18, 2021 - Benefits of Screening Key Question 1. … Accuracy of Screening Key Question 2. … Harms of Screening Key Question 3. … Key Question 1: Overall Summary of Impact of Screening vs No Screening on Colorectal Cancer Incidence … Key Question 2: Summary of Test Accuracy Results From Studies With Colonoscopy Follow-Up for Stool and

400. Evidence Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
     January 19, 2021 - Health Benefits of Interventions Key Question 1. … among men at high risk for cardiorespiratory disease. 96 Cessation Benefits of Interventions Key Question … Health Benefits of Interventions Key Question 1. … Cessation Benefits of Interventions Key Question 2. … smokeless tobacco users Varenicline February 2014 3   ✓ ✓ Abbreviations: KQ, key question